PVS for Providers

Ideal patient candidates for Premier Vascular EECP Therapy are patients who

  • Have chronic stable angina
  • Are not receiving adequate relief from angina from current medications
  • Do not qualify or prefer not to undergo invasive procedures (bypass surgery, angioplasty, or stenting)
  • Have failed traditional therapies such as PCI and/or CABG

Benefits of offering patients this treatment option:

  • Treatment is safe with negligible side effects
  • No recovery time required
  • Effective with virtually all patients
  • Lasting benefit to patients
  • Non-invasive
  • Painless
  • Covered by Medicare and Insurance
  • Inexpensive

Some of the conditions EECP Therapy can treat include

What conditions can EECP Treat?

  • Chest pain
  • Cough
  • Fatigue
  • Shortness of breath (dyspnea)

It can also help with other conditions such as:

  • Cardiac syndrome X (a type of angina).
  • Cerebrovascular disease.
  • Heart failure.
  • Kidney (renal) failure.
  • Left ventricular dysfunction (an early stage of heart failure).
  • Lung disease (pulmonary disease).
  • Peripheral artery (vascular) disease (PAD).

Contraindications

EECP cannot treat unstable angina (acute coronary syndrome)

EECP Therapy is not indicated for patients who have:

  • Heart rate over 120 beats per minute
  • Aortic insufficiency
  • Recent cardiac catheterization
  • Irregular heart rhythm such as atrial fibrillation
  • Severe hypertension (high blood pressure)
  • Peripheral artery disease involving the legs
  • A congenital heart defect
  • Hypertrophic cardiomyopathy
  • Valvular disease
  • Enlarged heart
  • A pacemaker
  • Pulmonary hypertension
  • History of deep venous thrombosis
  • History of smoking – Smoking reduces blood vessel function counteracting the positive effects of EECP

Outcomes & Research

In 2014, several professional organizations agreed in a focused update that EECP treatment ought to be considered for patients with angina that have not been helped by other treatments. These organizations are:

  • The American College of Cardiology
  • American Heart Association
  • American Association for Thoracic Surgery
  • Preventive Cardiovascular Nurses Association
  • Society for Cardiovascular Angiography and Interventions
  • The Society of Thoracic Surgeons

In 1998, The Mayo Clinic began using EECP to treat patients with refractory angina. For 25 years, they have integrated this therapy into their cardiac rehabilitation therapy program.

Referral Process

To refer a patient download the referral form.

FAQs

Your cardiologist may not have offered EECP treatment to you for several reasons, including your underlying health history and specific treatment plan. It’s not considered a first-line treatment for angina, even though it can decrease the need for common medications like nitroglycerin.

Treatment availability also may be a factor, because not all communities have accessible EECP equipment. Patient travel time can be a barrier to keeping appointments and completing the necessary full course of EECP treatment. EECP has become more common in the United States, though, and about 1,200 machines are now in operation across the country.

EECP treatment applies pressure to blood vessels in your lower limbs. The pressure increases blood flow back to your heart, so your heart works better. When your heart pumps better, symptoms ease.

This type of therapy can also encourage blood vessels to open new pathways for blood to flow to your heart. These pathways eventually become “natural bypass” vessels that help relieve symptoms of angina if your coronary arteries are narrowed or blocked.

Hundreds of thousands of people worldwide have received EECP therapy. This treatment relieves heart disease symptoms that can’t be controlled by medicine or treated with surgery.

EECP therapy does not require a hospital stay. You can return to your regular routine immediately after treatment. Alert your healthcare provider if you experience any side effects. Many people experience improved blood flow and reduced symptoms of angina for several years after treatment. In some cases, you may need another course of EECP therapy.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Mike Hardson

Mike Hardson

Patient

Edna Marxten

Edna Marxten

Patient

Kevin Martin

Kevin Martin

Patient

Jessica Brown

Jessica Brown

Doctor

David Cooper

David Cooper

Doctor